Berberine and Your Medications: What to Check First

Berberine is a compound found in goldenseal, barberry, Oregon grape, coptis and tree turmeric. The NIH LiverTox drug record lists what it is sold for: obesity, diabetes, high blood lipids, heart failure, stomach infection, and prevention of colon polyps.

Then it adds the sentence the marketing never carries. Berberine has not been approved for any of these uses in the United States.

There are real human trials behind some of that list. They ran in patients being treated for a diagnosed condition, under supervision, alongside their regular care. That is a different situation from a healthy adult adding a capsule at home, and the difference matters more than the headline does.

The NCCIH factsheet on goldenseal puts it plainly. Goldenseal may change the way your body processes many medications. In a study NCCIH funded, levels of metformin, the most commonly prescribed diabetes medicine, decreased about 25 percent in healthy adults given goldenseal extract alongside it. NCCIH says that drop was enough to potentially hinder glucose control in people with type 2 diabetes taking metformin.

There is an honest complication, and it cuts both ways. NCCIH also notes that when people take goldenseal by mouth, very little berberine may be absorbed, so results from berberine studies may not apply to goldenseal. The plant and the isolated compound are not interchangeable in either direction.

Which is exactly why this belongs to a pharmacist rather than to an article. The NCCIH guide to supplement and medication interactions describes the three ways it can go: a supplement can increase a medication's effects, decrease them, or interact in harmful ways. None of the three announces itself.

NCCIH is direct about who should not use goldenseal. Women who are pregnant or breastfeeding should not use it, and it should not be given to infants, because the berberine in it can be harmful to newborns. That is not a caution to weigh. It is a stop.

The liver worry, on the other hand, is smaller than the internet suggests. LiverTox gives berberine a likelihood score of E, an unlikely cause of clinically apparent liver injury. It has not been linked to enzyme elevations during therapy, and in published trials the side effects were minor and no more frequent than with placebo. The honest caveat is that few human studies have reported laboratory results in any detail.

The ODS supplement guide supplies the last piece. The FDA does not determine whether a dietary supplement is effective before it is marketed, and seals from groups such as NSF International and US Pharmacopeia mean a product was properly made, not that it is safe or that it works.